Core Viewpoint - Cognizant (CTSH) is expected to report quarterly earnings of $1.26 per share, a 7.7% increase year-over-year, with revenues projected at $5.19 billion, reflecting a 7.1% year-over-year growth [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 0.1%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenue- Products and Resources' at $1.25 billion, representing an 11% increase from the previous year [5]. - 'Revenue- Health Sciences' is projected to be $1.61 billion, indicating a 10.1% year-over-year change [5]. - 'Revenue- Financial Services' is expected to reach $1.52 billion, reflecting a 5.3% increase year-over-year [5]. - 'Revenue- Communications, Media and Technology' is forecasted at $826.36 million, showing a 1.3% year-over-year change [6]. Market Performance - Cognizant shares have returned -1.1% over the past month, contrasting with the Zacks S&P 500 composite's +4.6% change [6]. - With a Zacks Rank 2 (Buy), Cognizant is anticipated to outperform the overall market in the near future [6].
What Analyst Projections for Key Metrics Reveal About Cognizant (CTSH) Q2 Earnings